drugset / Trial / NCT02468323

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia

NCT02468323

Phase 4 Completed 150 enrolled Hospital de Base
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study aims to compare the quality of perioperative antiemesis of palonosetron and ondansetron in patients undergoing cesarean section

Timeline

Start
2015-10
Primary completion
2017-02
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg Intravenous
Subject Palonosetron Other / unclassified 75 ug Intravenous

Indications

No indication recorded.